Literature DB >> 22855495

Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses.

Nigel J McLeish1, Çigdem H Williams, Dimitrios Kaloudas, Merja M Roivainen, Glyn Stanway.   

Abstract

Coxsackievirus A9 (CAV9), a member of the Picornaviridae family, uses an RGD motif in the VP1 capsid protein to bind to integrin αvβ6 during cell entry. Here we report that two CAV9 isolates can bind to the heparan sulfate/heparin class of proteoglycans (HSPG). Sequence analysis identified an arginine (R) at position 132 in VP1 in these two isolates, rather than a threonine (T) as seen in the nonbinding strains tested. We introduced a T132R substitution into the HSPG-nonbinding strain Griggs and recovered infectious virus capable of binding to immobilized heparin, unlike the parental Griggs strain. The known CAV9 structure was used to identify the location of VP1 position 132, 5 copies of which were found to cluster around the 5-fold axis of symmetry, presumably producing a region of positive charge which can interact with the negatively charged HSPG. Analysis of several enteroviruses of the same species as CAV9, Human enterovirus B (HEV-B), identified examples from 5 types in which blocking of infection by heparin was coincident with an arginine (or another basic amino acid, lysine) at a position corresponding to 132 in VP1 in CAV9. Together, these data show that membrane-associated HSPG can serve as a (co)receptor for some CAV9 and other HEV-B strains and identify symmetry-related clustering of positive charges as one mechanism by which HSPG binding can be achieved. This is a potentially powerful mechanism by which a single amino acid change could generate novel receptor binding capabilities, underscoring the plasticity of host-cell interactions in enteroviruses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22855495      PMCID: PMC3457184          DOI: 10.1128/JVI.00640-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Virus-polysaccharide interactions. I. An agar polysaccharide determining plaque morphology of EMC virus.

Authors:  K K TAKEMOTO; H LIEBHABER
Journal:  Virology       Date:  1961-08       Impact factor: 3.616

2.  Human rhinovirus type 54 infection via heparan sulfate is less efficient and strictly dependent on low endosomal pH.

Authors:  Abdul Ghafoor Khan; Johannes Pichler; Anke Rosemann; Dieter Blaas
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

3.  Primary attachment of murine leukaemia virus vector mediated by particle-associated heparan sulfate proteoglycan.

Authors:  Nina Kureishy; Daisy Faruque; Colin D Porter
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

4.  N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells.

Authors:  Andreas E Zautner; Birgit Jahn; Elke Hammerschmidt; Peter Wutzler; Michaela Schmidtke
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate.

Authors:  T Jackson; F M Ellard; R A Ghazaleh; S M Brookes; W E Blakemore; A H Corteyn; D I Stuart; J W Newman; A M King
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment.

Authors:  Markete Vlasak; Irene Goesler; Dieter Blaas
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells.

Authors:  Sun-Ku Chung; Joo-Young Kim; In-Beom Kim; Sang-Ick Park; Kyung-Hee Paek; Jae-Hwan Nam
Journal:  Virology       Date:  2005-03-01       Impact factor: 3.616

8.  Cell-surface interactions of echovirus 22.

Authors:  T Pulli; E Koivunen; T Hyypiä
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

9.  The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex.

Authors:  E E Fry; S M Lea; T Jackson; J W Newman; F M Ellard; W E Blakemore; R Abu-Ghazaleh; A Samuel; A M King; D I Stuart
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

10.  Structure of Foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation.

Authors:  Elizabeth E Fry; John W I Newman; Stephen Curry; Saloua Najjam; Terry Jackson; Wendy Blakemore; Susan M Lea; Laura Miller; Alison Burman; Andrew M Q King; David I Stuart
Journal:  J Gen Virol       Date:  2005-07       Impact factor: 3.891

View more
  19 in total

1.  Human astrocytic cells support persistent coxsackievirus B3 infection.

Authors:  Xiaowei Zhang; Zhenhua Zheng; Bo Shu; Xijuan Liu; Zhenfeng Zhang; Yan Liu; Bingke Bai; Qinxue Hu; Panyong Mao; Hanzhong Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry.

Authors:  Zhiqiang Ku; Xiaohua Ye; Jinping Shi; Xiaoli Wang; Qingwei Liu; Zhong Huang
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

3.  A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans.

Authors:  Che C Colpitts; Luis M Schang
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

4.  Positively charged residues at the five-fold symmetry axis of cell culture-adapted foot-and-mouth disease virus permit novel receptor interactions.

Authors:  Stephen Berryman; Stuart Clark; Naresh K Kakker; Rhiannon Silk; Julian Seago; Jemma Wadsworth; Kyle Chamberlain; Nick J Knowles; Terry Jackson
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

5.  Initial evidence on differences among Enterovirus 71, Coxsackievirus A16 and Coxsackievirus B4 in binding to cell surface heparan sulphate.

Authors:  Hamid Reza Pourianfar; Kristin Kirk; Lara Grollo
Journal:  Virusdisease       Date:  2013-12-04

6.  Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor.

Authors:  Chee Wah Tan; Chit Laa Poh; I-Ching Sam; Yoke Fun Chan
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

7.  Structures of the procapsid and mature virion of enterovirus 71 strain 1095.

Authors:  Javier O Cifuente; Hyunwook Lee; Joshua D Yoder; Kristin L Shingler; Michael S Carnegie; Jennifer L Yoder; Robert E Ashley; Alexander M Makhov; James F Conway; Susan Hafenstein
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

8.  A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody.

Authors:  Hyunwook Lee; Javier O Cifuente; Robert E Ashley; James F Conway; Alexander M Makhov; Yoshio Tano; Hiroyuki Shimizu; Yorihiro Nishimura; Susan Hafenstein
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

9.  Endocytosis of integrin-binding human picornaviruses.

Authors:  Pirjo Merilahti; Satu Koskinen; Outi Heikkilä; Eveliina Karelehto; Petri Susi
Journal:  Adv Virol       Date:  2012-11-27

10.  Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction.

Authors:  Yorihiro Nishimura; Hyunwook Lee; Susan Hafenstein; Chikako Kataoka; Takaji Wakita; Jeffrey M Bergelson; Hiroyuki Shimizu
Journal:  PLoS Pathog       Date:  2013-07-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.